Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;89(3):345-7.
doi: 10.1038/clpt.2010.267.

Physician barriers to incorporating pharmacogenetic treatment strategies for nicotine dependence into clinical practice

R A Schnoll  1 , A E Shields
Affiliations

Physician barriers to incorporating pharmacogenetic treatment strategies for nicotine dependence into clinical practice

R A Schnoll et al. Clin Pharmacol Ther. 2011 Mar.

Abstract

Advances in genomics research may improve health outcomes by tailoring treatment according to patients' genetic profiles. The treatment of nicotine dependence, in particular, may soon encompass pharmacogenetic treatment models. Realizing the benefits of such treatment strategies may depend on physicians' preparedness to incorporate genetic testing into clinical practice. This article describes barriers to clinical integration of pharmacogenetic treatments that will need to be addressed to realize the benefits of individualized smoking-cessation treatment.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declared no conflict of interest.

References

    1. Ray R, Schnoll RA, Lerman C. Nicotine dependence and pharmacogenetics. In: Steptoe A, editor. Handbook of Behavioral Medicine. New York: Springer; 2010.
    1. Shields AE, Blumenthal D, Weiss KB, Comstock CB, Currivan D, Lerman C. J. Gen. Intern. Med. Vol. 20. 2005. Barriers to translating emerging genetic research on smoking into clinical practice: perspectives of primary care physicians; pp. 131–138. - PMC - PubMed
    1. Shields AE, Levy DE, Blumenthal D, Currivan D, McGinn-Shapiro M, Weiss KB, et al. Primary care physicians’ willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics. Nicotine Tob. Res. 2008;10:1037–1045. - PMC - PubMed
    1. Shields AE, Lerman C. Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready? Clin. Pharmacol. Ther. 2008;83:635–639. - PubMed
    1. Levy DE, Youatt EJ, Shields AE. Primary care physicians’ concerns about offering a genetic test to tailor smoking cessation treatment. Genet. Med. 2007;9:842–849. - PubMed

Publication types